Literature DB >> 11323402

Mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TTK in human bladder cancer, screening for mutations and loss of heterozygosity.

S H Olesen1, T Thykjaer, T F Ørntoft.   

Abstract

Chromosomal instability is common in bladder cancer and could be caused by mutations of mitotic checkpoint genes. Therefore we screened for mutations of the mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TTK in six aneuploid bladder cancer cell lines and 15 human bladder tumours. The screening was performed by sequence analysis of the entire coding regions of the four genes. No mutations were detected in any of the four genes. We detected several sequence variations in hBUB1, hBUB1B and TTK both new and previously published. The genetic stability of the four gene loci were tested by loss of heterozygosity (LOH) analysis in the 15 patient samples, showing one LOH for each of the hBUB1B, hBUB3 and TTK loci (6.7%) of the cases, all in different tumour samples. No LOH was detected at hBUB1. We conclude that both mutational inactivation, and loss of one allele, of the examined mitotic checkpoint genes are relatively uncommon.

Entities:  

Mesh:

Year:  2001        PMID: 11323402     DOI: 10.1093/carcin/22.5.813

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  13 in total

1.  Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM).

Authors:  Hannah Carter; Josue Samayoa; Ralph H Hruban; Rachel Karchin
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

Review 2.  The MPS1 family of protein kinases.

Authors:  Xuedong Liu; Mark Winey
Journal:  Annu Rev Biochem       Date:  2012-04-05       Impact factor: 23.643

3.  Genomic Instability and Cancer.

Authors:  Yixin Yao; Wei Dai
Journal:  J Carcinog Mutagen       Date:  2014

4.  BUB1 immunolocalization in breast carcinoma: its nuclear localization as a potent prognostic factor of the patients.

Authors:  Kiyoshi Takagi; Yasuhiro Miki; Yukiko Shibahara; Yasuhiro Nakamura; Akiko Ebata; Mika Watanabe; Takanori Ishida; Hironobu Sasano; Takashi Suzuki
Journal:  Horm Cancer       Date:  2013-01-04       Impact factor: 3.869

Review 5.  Studying chromosome instability in the mouse.

Authors:  Floris Foijer; Viji M Draviam; Peter K Sorger
Journal:  Biochim Biophys Acta       Date:  2008-07-26

Review 6.  Mitotic checkpoint control and chromatin remodeling.

Authors:  Yixin Yao; Wei Dai
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

7.  Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations.

Authors:  Naotaka Nishiyama; Eri Arai; Ryo Nagashio; Hiroyuki Fujimoto; Fumie Hosoda; Tatsuhiro Shibata; Taiji Tsukamoto; Sana Yokoi; Issei Imoto; Johji Inazawa; Yae Kanai
Journal:  Carcinogenesis       Date:  2010-12-22       Impact factor: 4.944

8.  The accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expression.

Authors:  Li Bie; Gang Zhao; Pui Cheng; Gaelle Rondeau; Steffen Porwollik; Yan Ju; Xiao-Qin Xia; Michael McClelland
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

9.  BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers.

Authors:  Y-K Lee; E Choi; M A Kim; P-G Park; N-H Park; H Lee
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

10.  Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression.

Authors:  Sujun Hua; Caleb B Kallen; Ruby Dhar; Maria T Baquero; Christopher E Mason; Beth A Russell; Parantu K Shah; Jiang Liu; Andrey Khramtsov; Maria S Tretiakova; Thomas N Krausz; Olufunmilayo I Olopade; David L Rimm; Kevin P White
Journal:  Mol Syst Biol       Date:  2008-04-15       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.